1. Targeting the Interplay Between Cancer Fibroblasts, Mesenchymal Stem Cells, and Cancer Stem Cells in Desmoplastic Cancers
   Tze-Sian Chan et al, 2019, Frontiers in Oncology CrossRef
2. Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer
   Masahiro Uehara et al, 2024, Cancer Drug Resistance CrossRef
3. Substrate Stiffness Modulates the Growth, Phenotype, and Chemoresistance of Ovarian Cancer Cells
   Yali Fan et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
4. The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma
   Hongmei Cui et al, 2021, Frontiers in Pharmacology CrossRef
5. The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms
   Malihe Rezaee et al, 2023, Frontiers in Pharmacology CrossRef
6. Ginsenoside Re Suppress the Proliferation and Migration of MCF-7 Human Breast Cancer Cells
   Jin-Nyoung Ho, 2024, Journal of the Korean Society of Food Science and Nutrition CrossRef
7. SCRIB Is Involved in the Progression of Ovarian Carcinomas in Association with the Factors Linked to Epithelial-to-Mesenchymal Transition and Predicts Shorter Survival of Diagnosed Patients
   Usama Khamis Hussein et al, 2021, Biomolecules CrossRef
8. RNA sequencing and bioinformatics analysis revealed PACSIN3 as a potential novel biomarker for platinum resistance in epithelial ovarian cancer
   Gwan Hee Han et al, 2022, The Journal of Gene Medicine CrossRef
9. Twist1-Mediated Adriamycin-Induced Epithelial-Mesenchymal Transition Relates to Multidrug Resistance and Invasive Potential in Breast Cancer Cells
   Qing-Quan Li et al, 2009, Clinical Cancer Research CrossRef
10. ATF3 characterizes aggressive drug-tolerant persister cells in HGSOC
    Kathrin Böpple et al, 2024, Cell Death & Disease CrossRef
11. Dual Effects of Non-Coding RNAs (ncRNAs) in Cancer Stem Cell Biology
    Athina A. Kyriazi et al, 2020, International Journal of Molecular Sciences CrossRef
12. Comparing the Secretomes of Chemorefractory and Chemoresistant Ovarian Cancer Cell Populations
    Amy H. Lee et al, 2022, Cancers CrossRef
13. Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer
    Ishwar N. Kohale et al, 2022, Cancers CrossRef
14. Loss of RhoB Expression Promotes Migration and Invasion of Human Bronchial Cells Via Activation of AKT1
    Emilie Bousquet et al, 2009, Cancer Research CrossRef
15. Slug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
    Tzu-Hua Chang et al, 2011, American Journal of Respiratory and Critical Care Medicine CrossRef
16. The role of epithelial–mesenchymal transition-regulating transcription factors in anti-cancer drug resistance
    Jihye Seo et al, 2021, Archives of Pharmacal Research CrossRef
17. Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC
    Andrew Sulaiman et al, 2021, Biomedicines CrossRef
18. Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
    Zhiwei Wang et al, 2009, Cancer Research CrossRef
19. Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related to the Epithelial-Mesenchymal Transition
    Jingjing Sha et al, 2021, Biomolecules CrossRef
20. Immunoglobulins and serum proteins impair anti-tumor NK cell effector functions in malignant ascites
    Antonio Hrvat et al, 2024, Frontiers in Immunology CrossRef
21. Specific c-Jun N-Terminal Kinase Inhibitor, JNK-IN-8 Suppresses Mesenchymal Profile of PTX-Resistant MCF-7 Cells through Modulating PI3K/Akt, MAPK and Wnt Signaling Pathways
    Pelin Ozfiliz Kilbas et al, 2020, Biology CrossRef